tbuckley/cabot-search huggingface dataset:
<i>Vital Signs</i>: Burden and Prevention of Influenza and Pertussis Among Pregnant Women and Infants — United States
Authors: Megan C. Lindley, Katherine E. Kahn, Barbara H. Bardenheier, Denise V. D’Angelo, Fatimah S. Dawood, Rebecca V. Fink, Fiona Havers, Tami H. Skoff
Journal: MMWR Morbidity and Mortality Weekly Report (2019)

Vaccinating pregnant women with influenza vaccine and tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) can reduce influenza and pertussis risk for themselves and their infants.Surveillance data were analyzed to ascertain influenza-associated hospitalization among pregnant women and infant hospitalization and death associated with influenza and pertussis. An Internet panel survey was conducted during March 27-April 8, 2019, among women aged 18-49 years who reported being pregnant any time since August 1, 2018. Influenza vaccination before or during pregnancy was assessed among respondents with known influenza vaccination status who were pregnant any time during October 2018-January 2019 (2,097). Tdap receipt during pregnancy was assessed among respondents with known Tdap status who reported a live birth by their survey date (817).From 2010-11 to 2017-18, pregnant women accounted for 24%-34% of influenza-associated hospitalizations per season among females aged 15-44 years. From 2010 to 2017, a total of 3,928 pertussis-related hospitalizations were reported among infants aged <2 months (annual range = 262-743). Maternal influenza and Tdap vaccination coverage rates reported as of April 2019 were 53.7% and 54.9%, respectively. Among women whose health care providers offered vaccination or provided referrals, 65.7% received influenza vaccine and 70.5% received Tdap. The most commonly reported reasons for nonvaccination were believing the vaccine is not effective (influenza; 17.6%) and not knowing that vaccination is needed during each pregnancy (Tdap; 37.9%), followed by safety concerns for the infant (influenza =15.9%; Tdap = 17.1%).Many pregnant women do not receive the vaccines recommended to protect themselves and their infants, even when vaccination is offered. CDC and provider organizations' resources are available to help providers convey strong, specific recommendations for influenza and Tdap vaccination that are responsive to pregnant women's concerns.
Abstract 363: Examination of the Effects of Extracorporeal Cardiopulmonary Resuscitation on Sublingual Microcirculation in a Swine Model of Cardiac Arrest
Authors: Brendan M McCracken, Mohamad H Tiba, Brandon C Cummings, Carmen I Colmenero, Alvaro Rojas-Pena, Pavel Hala, Matias Caceres, Cindy H Hsu, Aaron Prater, Jensyn J VanZalen, Kevin R Ward, Robert H Bartlett, Robert W Neumar
Journal: Circulation (2018)

Background: Extracorporeal CPR (ECPR) is used to provide circulatory stability for organ perfusion and oxygen delivery (DO 2 ) after refractory cardiac arrest (CA). Hemodynamic measurements during ECPR may not necessarily indicate adequate perfusion at the microcirculatory level where DO 2 , oxygen consumption (VO 2 ), and oxygen exchange (O 2 ER) are most critical. In this study, we used sidestream dark-field imaging to measure total vessel density (TVD) to evaluate sublingual microcirculatory flow in a swine model of refractory CA and ECPR. Hypothesis: We hypothesize that TVD can provide real-time assessment of tissue perfusion during post-cardiac arrest ECPR that correlates with traditional measures of tissue oxygenation. Methods: Swine (8) were anesthetized and instrumented for hemodynamic monitoring. Ventricular fibrillation (VF) was induced and CPR initiated after 8min. CPR was administered using a combination of manual and mechanical chest compressions. During CPR the femoral vessels were instrumented for delivery of veno-arterial ECPR. ECPR was initiated 45min after arrest to simulate refractory CA. Sublingual TVD was measured at baseline and after 15min, 1, 2, and 3 hours of ECPR. Results: A one-way ANOVA showed significant difference between baseline TVD: 12.2(2.3)mm -1 and at 3 hours into ECPR: 6.4(3.0)mm -1 (p=0.005). TVD was highly correlated with circuit flow but not with Mean Arterial Pressure (MAP) (r=0.903, p=0.036; r=0.063, p=0.920). In addition, TVD was highly correlated with DO 2 , and lactate, (r= 0.897, p=0.039; r=-0.883, p=0.047) and moderately with VO 2 , O 2 ER, and ScvO 2 (r= 0.776, -0.370, 0.558) respectively. Conclusion: TVD appears to provide a reliable real-time assessment of tissue perfusion during post-cardiac arrest ECPR. The relationships between TVD and MAP, and TVD and flow also suggest that optimization of flow may be more important than optimizing pressure to achieve adequate tissue perfusion during ECPR.
Acquired Von Willebrand Syndrome In Mitral Valve Leak
Authors: Almudena Pérez-Rodríguez, Maria Joana Costa Pinto Prego de Faria, Esther Lourés Fraga, Angela Rodríguez-Trillo, José Joaquín Cuenca, Javier Batlle, Maria Fernanda López-Fernández
Journal: Blood (2010)
Outcome of Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients Treated with Various Frontline Second-Generation Tyrosine Kinase Inhibitors: A Single-Center Experience
Authors: Sung-Eun Lee, Soo Young Choi, Soo-Hyun Kim, Hye-Young Song, Hea-Lyun Yoo, Mi-Young Lee, Ki-Hoon Kang, Hee-Jeong Hwang, Eun-Jung Jang, Dong-Wook Kim
Journal: Blood (2015)
Allogeneic Stem Cell Transplantation Confers a Favorable Outcome in Patients with NPM1 Positive Acute Myeloid Leukemia: Results From a Donor Vs. No-Donor Analysis of 309 Patients Treated in the SAL AML-2003 Trial
Authors: Christoph Röllig, Martin Bornhäuser, Christian Thiede, Michael Kramer, Anthony Ho, Hannes Wandt, Mathias Hänel, Hermann Einsele, Walter E. Aulitzky, Norbert Schmitz, Wolfgang E. Berdel, Matthias Stelljes, Joachim Kienast, Eckhard Thiel, Stefan W. Krause, Friedrich Stölzel, Uwe Platzbecker, Markus Schaich, Johannes Schetelig, Gerhard Ehninger
Journal: Blood (2011)
Proteomic Profiling of AML Bone Marrow-Derived Mesenchymal Stem Cells (MSC) Reveals Marked Differences From Normal MSC.
Authors: Rui-yu Wang, Yi Hua Qiu, Suk Young Yoo, Teresa McQueen, Ye Chen, Zhihong Zeng, Kevin R. Coombes, Wendy D. Schober, Marina Konopleva, Steven M. Kornblau, Michael Andreeff
Journal: Blood (2012)
Differentiation on Biological Basis of Monoclonal B-Cell Lymphocytosis (MBL) From Chronic Lymphocytic Leukemia (CLL): Results of a Prospective GISL (Gruppo Italiano Studio Linfomi) Trial
Authors: Stefano Molica, Sonia Fabris, Giovanna Cutrona, Serena Matis, Emanuela Anna Pesce, Francesco Maura, Gabriella Ciceri, Francesco Di Raimondo, Caterina Musolino, Marco Gobbi, Nicola Di Renzo, Francesca Romana Mauro, Renato Cantaffa, Maura Brugiatelli, Francesco Merli, Simonetta Zupo, Caterina Mammi, Luca Baldini, Francesco Angrilli, Gianni Quintana, Ugo Consoli, Emilio Iannitto, Paolo Di Tonno, Alberto Fragasso, Pellegrino Musto, Maria Cristina Cox, Gainluca Festini, Vincenzo Callea, Stefano Sacchi, Agostino Cortelezzi, Giorgio Lambertenghi Deliliers, Robin Foà, Massimo Federico, Antonino Neri, Manlio Ferrarini, Fortunato Morabito
Journal: Blood (2010)
HBV Reverse Seroconversion and Intervention with Vaccination after Allogeneic HSCT in Patients with Previous HBV Infection.
Authors: Masahiro Onozawa, Hiroe Kanamori, Kaoru Kahata, Takeshi Kondo, Shuichi Ota, Satoshi Hashino, Junji Tanaka, Masahiro Imamura, Masahiro Asaka
Journal: Blood (2006)
Successful Autologous Peripheral Blood Stem Cell Transplantation in 3 Women with POEMS Syndrome: A Single Centre Experience
Authors: Giusy Antolino, Giovanni Antonini, Antonella Ferrari, Giacinto La Verde, Raffaele Porrini, Francesca Saltarelli, Esmeralda Conte, Barbara Veggia, Virginia Naso, Pamela Latino, William Arcese, Enrico Montefusco
Journal: Blood (2011)
Updated Safety and Preliminary Efficacy Data from a Phase 1b Study Combining Venetoclax (GDC-0199, ABT-199) with Bendamustine/Rituximab in Patients with Relapsed/Refractory or Previously Untreated Chronic Lymphocytic Leukemia
Authors: Gilles A. Salles, Thomas E. Boyd, Franck Morschhauser, Clemens-Martin Wendtner, Michael Hallek, Barbara F. Eichhorst, Mark Kozloff, Guillaume Cartron, Yan Li, James Hilger, Mehrdad Mobasher, Stephan Stilgenbauer
Journal: Blood (2015)
Co-Transplantation of Autologous Umbilical Cord Matrix Mesenchymal Stem Cells Improves Engraftment of Umbilical Cord Blood in NOD/SCID Mice.
Authors: Robb Friedman, Monica Betancur, Hande Tuncer, Laurent Boissel, Curtis Cetrulo, Hans-Georg Klingemann
Journal: Blood (2006)
An Intergroup Randomised Trial of Standard Intensity Versus Reduced Intensity TBI-Based Conditioning In Patients with Acute Myeloid Leukemia in First Complete Remission
Authors: Martin Bornhauser, Joachim Kienast, Rudolf Trenschel, Andreas Burchert, Ute Hegenbart, Michael Stadler, Herrad Baurmann, K. Schäfer-Eckart, Ernst Holler, Nicolaus Kröger, Christoph Schmid, Hermann Einsele, Michael Kiehl, Rainer Schwerdtfeger, Arnold Ganser, Peter Dreger, Andreas Neubauer, Wolfgang E. Berdel, Gerhard Ehninger, Dietrich Beelen, Johannes Schetelig, Matthias Stelljes
Journal: Blood (2011)
Inherited GPI-Anchor Deficiencies Caused By The Hypomorphic Mutations In PIG A gene: Comparison To Paroxysmal Nocturnal Hemogrobinuria
Authors: Yoshiko Murakami, Mitsuhiro Kato, Hirotomo Saitsu, Kenjiro Kikuchi, Shuei Watanabe, Mizue Iai, Ryuki Matsuura, Rumiko Takayama, Chihiro Ohba, Shin-ichiro Hamano, Hitoshi Osaka, Kiyoshi Hayasaka, Naomichi Matsumoto, Taroh Kinoshita
Journal: Blood (2013)
Impact of <i>IL1RN</i> Variants on Response to Interleukin‐1 Blocking Therapy in Systemic Juvenile Idiopathic Arthritis
Authors: Claas Hinze, Sabrina Fuehner, Christoph Kessel, Helmut Wittkowski, Elke Lainka, Melanie Baehr, Boris Hügle, Johannes‐Peter Haas, Gerd Ganser, Elisabeth Weißbarth‐Riedel, Annette Jansson, Dirk Foell
Journal: Arthritis & Rheumatology (2019)

To analyze the reported association of IL1RN polymorphisms with response to interleukin-1 (IL-1) blockade in a German cohort of patients with systemic juvenile idiopathic arthritis (JIA), and to assess the impact of other factors on treatment response.Sixty-one patients with systemic JIA who had received IL-1 blockade were identified within the German Autoinflammatory Disease registry DNA biobank. Response to IL-1 blockade was assessed according to 1) the clinical response (initially at least a transient response or good response compared to a poor response), 2) switch (or no switch) to anti-IL-6 receptor therapy following IL-1 blockade, 3) achievement of clinically inactive disease within 6 months of IL-1 blockade, 4) improvement in disease activity measured using the modified Juvenile Arthritis Disease Activity Score, and 5) achievement of a glucocorticoid-free state. In addition, basic demographic data, key features of the disease course, laboratory data, and IL1RN single-nucleotide polymorphisms (SNPs) were assessed.Six of 7 IL1RN SNPs reported to be associated with response to anakinra therapy were analyzed. These 6 IL1RN SNPs were inherited as haplotypes. An association of IL1RN haplotypes and SNPs with response to IL-1 blockade could not be confirmed in this cohort of patients with systemic JIA. Patients who received tocilizumab following IL-1 blockade had a longer duration from disease onset to diagnosis than those who did not receive tocilizumab (median 0.27 years versus 0.08 years).The results of this study could not confirm an impact of IL1RN SNPs on response to IL-1 blockade therapy with either anakinra or canakinumab in a cohort of patients with systemic JIA. However, a longer time frame from disease onset to diagnosis was associated with poorer long-term treatment response, thereby supporting the "window of opportunity" hypothesis that suggests improved long-term treatment response with shorter time from disease onset to diagnosis (and treatment).
Targeted RNA Sequencing Is Capable of Identifying Thus Far Unknown Partner Genes in Leukemias with Rare Translocations and Provides Important Clinical and Therapeutical Information
Authors: Claudia Haferlach, Niroshan Nadarajah, Manja Meggendorfer, Nadine Dicht, Anna Stengel, Wolfgang Kern, Torsten Haferlach
Journal: Blood (2016)
A Phase II Trial Of Epigenetic Modulators Vorinostat In Combination With Azacitidine (azaC) In Patients With The Myelodysplastic Syndrome (MDS): Initial Results Of Study 6898 Of The New York Cancer Consortium
Authors: Lewis R. Silverman, Amit Verma, Rosalie Odchimar-Reissig, Eric J. Feldman, Shyamala C. Navada, Erin P Demakos, Maria R. Baer, Vesna Najfeld, Joseph A Sparano, Richard Piekarz
Journal: Blood (2013)
Defining the Speech and Language Therapist role in palliative care of neuro-oncology patients: A qualitative research study.
Authors: Rachel Evans, Mirella Longo, Annmarie Nelson
Journal: Neuro-Oncology (2019)

Abstract Speech and language therapists (SLTs) are experts in the management of swallowing and communication disorders. Although there is increasing recognition of SLTs in palliative care, evidence specifically supporting their role with primary malignant gliomas (PMG) patients is lacking, despite the prevalence of swallowing and communication difficulties in this non-curable disease. This study aimed to explore the contribution of SLT to PMG, as perceived by SLTs themselves and by members of the regional neuro-oncology multidisciplinary team (MDT). Following ethical approval, semi-structured one-to-one interviews were conducted with ten SLTs working with PMG in outpatients and community settings across South East Wales. In addition, five members of the regional neuro-oncology MDT were interviewed. Thematic analysis was used to analyse the data and to identify and pinpoint salient themes. The findings indicate that despite lack of professional guidance and previous evidence, SLTs provided evidence to suggest that they contribute beyond swallowing and communication management, to areas such as shared decision-making, key-working, patient advocacy, advanced care planning and support for psychological wellbeing. However, these extended roles are inconsistently recognised by the MDT. Five barriers were identified which hampered SLT contributions: a perceived identity crisis affecting PMG patients, lack of confidence from SLTs, inconsistent MDT integration, reduced resources and strategic direction. The study suggests that SLTs need to promote and educate the MDT in order to achieve routine integration and enhance patient-centred and holistic care. The profession may also benefit from capturing the value of their involvement with PMG to drive service developments.
Results of a Phase II Trial of Dasatinib As Frontline Therapy for Chronic Myeloid Leukemia (CML) In Chronic Phase (CP)
Authors: Naveen Pemmaraju, Hagop M. Kantarjian, Rajyalakshmi Luthra, Susan O'Brien, Elias Jabbour, Alfonso Quintas-Cardama, Gautam Borthakur, Farhad Ravandi, Srdan Verstovsek, Elizabeth Burton, Brenda Walker, Jorge E. Cortes
Journal: Blood (2011)
The Detection of Viral Infection in Bronchoalveolar Lavage Samples Collected From Recipients of Allogeneic Haematological Stem Cell Transplantation with Pneumonia (A 3 Year Epidemiological Study 2008–2010)
Authors: Eva Stepanova, Pavel Zak, Alzbeta Zavrelova, Melanie Cermanova, Jakub Radocha, Lenka Pliskova, Vlasta Stepanova, Lukas Smolej
Journal: Blood (2011)
Causes of Death for Patients with Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) Treated with Imatinib.
Authors: Andrea Renata Dean, Hagop M. Kantarjian, Susan O'Brien, Mary Beth Rios, Alfonso Quintas-Cardama, Elias Jabbour, Jianqin Shan, Jorge Cortes
Journal: Blood (2009)
At Least 20% Donor Myeloid Chimerism Is Necessary to Reverse the Sickle Phenotype after Allogeneic Hematopoietic Stem Cell Transplantation
Authors: Courtney D. Fitzhugh, Matthew M. Hsieh, Stefan Cordes, Tiffani Taylor, Wynona Coles, Katherine Roskom, John F. Tisdale
Journal: Blood (2016)
Comparison of Clinical and Biologic Significance of WT1 Mutations in Populations of Older (≥60 years[y]) and Younger (&lt;60 y) Adult Patients (Pts) with Cytogenetically Normal (CN) De Novo Acute Myeloid Leukemia (AML): a Cancer and Leukemia Group B (CALGB) Study.
Authors: Heiko Becker, Guido Marcucci, Kati Maharry, Michael D. Radmacher, Krzysztof Mrózek, Susan P. Whitman, Peter Paschka, Dean Margeson, Yue-Zhong Wu, Sebastian Schwind, Christian Langer, Maria R. Baer, Andrew J. Carroll, Michael A. Caligiuri, Jonathan E. Kolitz, Richard A. Larson, Clara D. Bloomfield
Journal: Blood (2009)
The Outcomes Of Allogeneic Stem Cell Transplantation In Patients With Mixed Phenotype Acute Leukemia (MPAL) Are Comparable To Those In Acute Myeloid Leukemia (AML) and Acute Lymphoblastic Leukemia (ALL): Results Of a Matched-Pair Analysis
Authors: Hiroaki Shimizu, Takayuki Saitoh, Shinichiro Machida, Shinichi Kako, Noriko Doki, Takehiko Mori, Toru Sakura, Yoshinobu Kanda, Heiwa Kanamori, Shuichi Miyawaki, Shinichiro Okamoto
Journal: Blood (2013)
FLT3-ITD Confers Resistance to Bortezomib By Protecting the mTOR/4EBP1 Pathway through Activation of STAT5 and Induction of Pim-1 Expression
Authors: Ayako Nogami, Keigo Okada, Gaku Oshikawa, Shinya Ishida, Hiroki Akiyama, Yoshihiro Umezawa, Tetsuya Kurosu, Osamu Miura
Journal: Blood (2015)
High dose statins on the high street: where are the data?
Authors: Andrew N Bamji
Journal: BMJ (2019)

Allowing pharmacists to prescribe high dose statins under the NHS plan is an extraordinary decision.1 People seem unable to grasp the difference between relative and absolute risk reduction no matter how often they are told. Statins might produce a relative reduction in cardiovascular events of 50%,2 but if the original absolute risk is 5%, then the absolute reduction is only …
Large-Scale High Resolution Integration of Copy Number and Gene Expression in DLBCL Reveals Focal and Frequent Deletions in Chromatin Modifying Genes with Outcome Correlation
Authors: Fong Chun Chan, Susana Ben-Neriah, Raymond Lim, Sandy Hu, Sanja Rogic, Nathalie Johnson, Ryan D Morin, Gavin Ha, Jiraui Ding, David W. Scott, Laurie H. Sehn, Joseph M. Connors, Marco A. Marra, Randy D. Gascoyne, Sohrab P Shah, Christian Steidl
Journal: Blood (2012)
Cellular Hydration and Oxidation As Phenotype Modifiers in Sickle Cell Anemia
Authors: Mary A Risinger, Neha Dagaonkar, Georgios E Christakopoulos, Jie Liu, Katie Giger Seu, Diamantis G Konstantinidis, Charles T Quinn, Satheesh Chonat, Clinton H Joiner, Kejian Zhang, Theodosia A Kalfa
Journal: Blood (2016)
Lyme disease: chronic illness is rare, say experts
Authors: Anna Harvey
Journal: BMJ (2019)

People who have had Lyme disease rarely develop chronic problems, experts have said, warning that those who seek treatment abroad believing their symptoms are a result of the infection may be putting themselves at risk.

There are around 1000 laboratory confirmed cases of Lyme disease in England and Wales annually, with an estimated 2000 more cases successfully treated in primary care without positive blood tests, said experts at a briefing on the disease at the Science Media Centre on 9 October.

Of these patients, fewer than one in 20 experience residual symptoms. …
A Prospective Evaluation of Neurocognitive Function and Neurologic Symptoms in Pediatric and Young Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) Undergoing Anti-CD22 Chimeric Antigen Receptor Therapy
Authors: Haneen Shalabi, Pamela L Wolters, Staci Martin, Cindy Delbrook, Bonnie Yates, Daniel W. Lee, Crystal L. Mackall, Terry J Fry, Nirali N Shah
Journal: Blood (2016)
Patients Under 50 Years of Age Do Not Present Specific Prognostic Characteristics: An IFM Study in 1897 Patients Under 65 Years of Age.
Authors: Virginie Roland, Michel Attal, Philippe Moreau, Claire Mathiot, Catherine Charbonnel, Denis Caillot, Thierry Facon, Cyrille Hulin, Gerald Marit, Stéphane Minvielle, Jean-Luc Harousseau, Herve Avet-Loiseau
Journal: Blood (2009)
Survival Disparities Between African-American and Caucasian Patients Treated with Autologous Stem Cell Transplantation for Multiple Myeloma Are Eliminated in the Era of Novel Therapeutics
Authors: Sairah Ahmed, Yvonne T Dinh, Sofia Qureshi, Gabriela Rondon, Qaiser Bashir, Simrit Parmar, Tiffany Avery, Robert Z. Orlowski, Richard Champlin, Muzaffar Qazilbash, Nina Shah
Journal: Blood (2011)
Serum Free Light Chain Analysis Improves Monitoring of Multiple Myeloma Patients Receiving First-Line Therapy with the Combination of Velcade, Doxil, and Dexamethasone (VDD).
Authors: Daniel Lebovic, Tara Kendall, Christine Brozo, Amanda McAllister, Malathi Hari, Sairah Alvi, Ewan J.D. Robson, Andrzej J. Jakubowiak
Journal: Blood (2007)
A Phase II Multi-Center Study of Lenalidomide, Subcutaneous Bortezomib and Dexamethasone (RsqVD) in Newly Diagnosed Multiple Myeloma - Ctrial-IE (ICORG) 13-17 Study
Authors: Peter O'Gorman, Michael E O'Dwyer, Oonagh Gilligan, John Quinn, Mark Coyne, Janusz Krawczyk, Philip T Murphy, Lourdes del Rosario McAlester, Orna Harraghy, Orlaith Cormican, Elizabeth Lenihan, Keith Egan, Meegahage Ratnakanthi Perera, Gerard Crotty, Patrick J Hayden, Brian Hennessy, Hilary M O'Leary, Kathleen Scott, Imelda Parker, Michele Cunnane, Jacinta Marron, Aoife Connell, Elizabeth Coghlan, Jacob P. Laubach, Paul G. Richardson
Journal: Blood (2016)
Phase II Prospective Multicentre Study Testing The Efficacy and Safety Of a Clofarabine (Clo), I.v. Busulfan (Bu) and Antithymocyte Globulins (ATG)-Based Reduced-Intensity Conditioning Regimen (RIC) Before Allogeneic Stem Cell Transplantation (allo-SCT) For High-Risk Myelodysplastic Syndrome Or Acute Leukemia: The Cloric Trial
Authors: Patrice Chevallier, Myriam Labopin, Gérard Socié, Stephane Vigouroux, Sabine Furst, Marie Y. Detrait, Bruno Lioure, Thierry Guillaume, Jacques Delaunay, Regis Peffault de la Tour, Noel Milpied, Didier Blaise, Mauricette Michallet, Karin Bilger, Philippe Moreau, Mohamad Mohty
Journal: Blood (2013)
Dasatinib in Patients with Chronic Phase Chronic Myeloid Leukemia (CML-CP) with Persistent, Low-Grade Nonhematologic Toxicity to Imatinib: Results from Dasperse (CA180-400)
Authors: Dong-Wook Kim, Charles S. Cleeland, Susanne Saussele, Loretta A. Williams, Hesham Mohamed, Javier Pinilla-Ibarz, Elisabetta Abruzzese
Journal: Blood (2015)
Synthetic 15-mer Peptide (PCK3145) Derived from Prostate Secretory Protein with In Vitro and In Vivo Activity Against Non-Hodgkin’s Lymphoma and Other Hematologic Malignancies.
Authors: Mireille Guerin, Cynthia Therien, Gorazd Krosl, Jinzi J. Wu, Helene Dulude, Chandra Panchal, Denis-Claude Roy
Journal: Blood (2007)
A New Generation of γGlobin Gene Inducers Act on Novel Molecular and Cellular Targets.
Authors: Susan Perrine, Marie Trudel, Serguei A. Castaneda, Rishikesh Mankidy, Michael S. Boosalis, Marthe-Sandrine Eiymo, Gary L. White, Regine Bohacek, Douglas V. Faller
Journal: Blood (2006)
Calr Mutants Retroviral Mouse Models Lead to a Myeloproliferative Neoplasm Mimicking an Essential Thrombocythemia Progressing to a Myelofibrosis
Authors: Caroline Marty, Nivarthi Harini, Christian Pecquet, Ilyas Chachoua, Vitalina Gryshkova, Jean-Luc Villeval, Stefan N. Constantinescu, Robert Kralovics, William Vainchenker, Isabelle Plo
Journal: Blood (2014)
A Phase I/II Trial of Fludarabine, Bendamustine, and Rituximab (FBR) Chemoimmunotherapy for Previously Treated Patients with CLL,
Authors: William G. Wierda, Kumudha Balakrishnan, Alessandra Ferrajoli, Tapan Kadia, Jorge E. Cortes, Susan O'Brien, Jan A. Burger, Francesco Paolo Tambaro, Annette Jalayer, Susan Lerner, Michael J Keating, Varsha Gandhi
Journal: Blood (2011)
Presence of Immunoglobulin Heavy Chain Gene (IGH) Translocations in Chronic Lymphocytic Leukemia Is Related to Poor Prognosis.
Authors: Grzegorz S. Nowakowski, Stephanie Smoley, Susan Schwager, Clive S. Zent, Timothy G. Call, Tait D. Shanafelt, Curtis A. Hanson, Renee C. Tschumper, Diane F. Jelinek, Daneil L. Van Dyke, Neil E. Kay
Journal: Blood (2007)